Trials / Completed
CompletedNCT00909844
Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study
Follow-up of the Phase III, Multicentre, Non Comparative, One Single Group, Open Study to Assess the Long-term Efficacy and Tolerability of Pamoate of Triptorelin 11.25 mg in Children With Precocious Puberty
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of the protocol is to assess the efficacy of triptorelin 11.25 mg with respect to the proportion of children who maintain a regression or stabilisation of sexual maturity until the end of the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Triptorelin (I.N.N.) | Decapeptyl® SR 11.25mg |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2015-04-01
- Completion
- 2016-01-01
- First posted
- 2009-05-29
- Last updated
- 2019-01-15
- Results posted
- 2017-05-01
Locations
10 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00909844. Inclusion in this directory is not an endorsement.